You may have heard of singulair, also known as montelukast. It is one of the most common allergy medications given to children, but it can be used in adults as well. The FDA has just added a new black box label to the popular allergy drug for “mental health issues.” Per the official statement, “The incidence of neuro-psychiatric events associated with montelukast is unknown, but some reports are serious, and many patients and health care professionals are not fully aware of these risks.” There will be more studies done to determine the actual incidence, but for now, be aware of this new development.
Read more here
Providers not to prescribe montelukast to patients with mild allergy symptoms
FDA warns that Singulair may cause depression and suicidal thoughts
